Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tedroff

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Acta Neurologica Scandinavica|March 1, 1992
Estimation of regional cerebral utilization of [11C]-L-3,4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomographyJ Tedroff, S M Aquilonius, P Hartvig, et al.
Acta Neurologica Scandinavica|February 1, 1992
Cerebral uptake and utilization of therapeutic [beta-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor responseJ Tedroff, S M Aquilonius, P Hartvig, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 1, 1995
Liquid chromatographic analysis of brain homogenates and microdialysates for the quantification of L-[beta-11C]DOPA and its metabolites for the validation of positron emission tomography studiesK J Lindner, P Hartvig, J Tedroff, et al.
Journal of Neural Transmission. General Section|January 1, 1992
Brain kinetics of 11 C-labelled L-tryptophan and 5-hydroxy-L-tryptophan in the rhesus monkey. A study using positron emission tomographyP Hartvig, K J Lindner, J Tedroff, et al.
Experimental Neurology|April 21, 2001
Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesionsW Pirker, J Tedroff, H Pontén, et al.
Clinical Neuropharmacology|January 1, 1992
PET studies with L-[11C]5-HTP and L-[11C]dopa in brains of healthy volunteers and patients with major depressionH Agren, L Reibring, P Hartvig, et al.
Journal of Neural Transmission. General Section|January 1, 1992
Regional brain kinetics of 6-fluoro-(beta-11C)-L-dopa and (beta-11C)-L-dopa following COMT inhibition. A study in vivo using positron emission tomographyP Hartvig, K J Lindner, J Tedroff, et al.
European Journal of Clinical Pharmacology|March 9, 2012
The dopaminergic stabilizer pridopidine is to a major extent N-depropylated by CYP2D6 in humansA Helldén, G Panagiotidis, P Johansson, et al.
Acta Radiologica. Supplementum|January 1, 1991
Positron emission tomography of [11C]5-hydroxytryptophan utilization in the brains of healthy volunteers and a patient with major depressionP Hartvig, H Agren, L Reibring, et al.
Journal of Neural Transmission. General Section|January 1, 1991
Brain kinetics of L-[beta-11C]dopa in humans studied by positron emission tomographyP Hartvig, H Agren, L Reibring, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Acta Neurologica Scandinavica|March 1, 1992
Estimation of regional cerebral utilization of [11C]-L-3,4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomographyJ Tedroff, S M Aquilonius, P Hartvig, et al.
Acta Neurologica Scandinavica|February 1, 1992
Cerebral uptake and utilization of therapeutic [beta-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor responseJ Tedroff, S M Aquilonius, P Hartvig, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 1, 1995
Liquid chromatographic analysis of brain homogenates and microdialysates for the quantification of L-[beta-11C]DOPA and its metabolites for the validation of positron emission tomography studiesK J Lindner, P Hartvig, J Tedroff, et al.
Journal of Neural Transmission. General Section|January 1, 1992
Brain kinetics of 11 C-labelled L-tryptophan and 5-hydroxy-L-tryptophan in the rhesus monkey. A study using positron emission tomographyP Hartvig, K J Lindner, J Tedroff, et al.
Experimental Neurology|April 21, 2001
Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesionsW Pirker, J Tedroff, H Pontén, et al.
Clinical Neuropharmacology|January 1, 1992
PET studies with L-[11C]5-HTP and L-[11C]dopa in brains of healthy volunteers and patients with major depressionH Agren, L Reibring, P Hartvig, et al.
Journal of Neural Transmission. General Section|January 1, 1992
Regional brain kinetics of 6-fluoro-(beta-11C)-L-dopa and (beta-11C)-L-dopa following COMT inhibition. A study in vivo using positron emission tomographyP Hartvig, K J Lindner, J Tedroff, et al.
European Journal of Clinical Pharmacology|March 9, 2012
The dopaminergic stabilizer pridopidine is to a major extent N-depropylated by CYP2D6 in humansA Helldén, G Panagiotidis, P Johansson, et al.
Acta Radiologica. Supplementum|January 1, 1991
Positron emission tomography of [11C]5-hydroxytryptophan utilization in the brains of healthy volunteers and a patient with major depressionP Hartvig, H Agren, L Reibring, et al.
Journal of Neural Transmission. General Section|January 1, 1991
Brain kinetics of L-[beta-11C]dopa in humans studied by positron emission tomographyP Hartvig, H Agren, L Reibring, et al.
Pageof 5